APRIEM ADVISORS – Regeneron Pharmaceuticals, Inc. Transaction History
APRIEM ADVISORS portfolio value:
$22.21M
portfolio value
APRIEM ADVISORS quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.09% | 28 shares | 3.16M | $688.87 | 32.24K |
| Q2 2022 | share | Increase | +0.26% | 82 shares | -3.4M | $591.13 | 32.22K |
| Q1 2022 | share | Increase | +1.22% | 386 shares | 2.39M | $698.42 | 32.13K |
| Q4 2021 | share | Increase | 0.00% | 31.75K shares | 20.05M | $642.51 | 31.75K |
| Q2 2017 | share | Decrease | -100.00% | -25 shares | -10K | $491.14 | 0 |
| Q1 2017 | share | 0.00% | 0 shares | 1K | $387.51 | 25 | |
| Q4 2016 | share | Decrease | -44.44% | -20 shares | -9K | $367.09 | 25 |
| Q3 2016 | share | 0.00% | 0 shares | 2K | $402.02 | 45 | |
| Q2 2016 | share | 0.00% | 0 shares | 0 | $349.23 | 45 | |
| Q1 2016 | share | 0.00% | 0 shares | -8K | $360.44 | 45 |